Baotran Ho

Pharmacologic Blockade of FAK Autophosphorylation Decreases Human Glioblastoma Tumor Growth and Synergizes with Temozolomide

Vita Golubovskaya, Grace Huang, Baotran Ho et al. · Molecular Cancer Therapeutics · 2012 · 80 citations · Full text

Medicine, Oncology, Pharmacology +17

Nanog Increases Focal Adhesion Kinase (FAK) Promoter Activity and Expression and Directly Binds to FAK Protein to Be Phosphorylated

Baotran Ho, Gretchen Olson, Sheila Figel et al. · Journal of Biological Chemistry · 2012 · 75 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth

Vita Golubovskaya, Baotran Ho, Min Zheng et al. · BMC Cancer · 2013 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17

MiR-138 and MiR-135 Directly Target Focal Adhesion Kinase, Inhibit Cell Invasion, and Increase Sensitivity to Chemotherapy in Cancer Cells

Vita Golubovskaya, Brittany L. Sumbler, Baotran Ho et al. · Anti-Cancer Agents in Medicinal Chemistry · 2014 · 56 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15

Vita Golubovskaya, Shalana O’Brien, Baotran Ho et al. · Journal of Cancer Research and Clinical Oncology · 2015 · 49 citations · Full text

Medicine, Cell Biology, Oncology +13